Literature DB >> 169283

Pattern of plasma ACTH, hGH, and cortisol during menstrual cycle.

A R Genazzani, T Lemarchand-Béraud, M L Aubert, J P Felber.   

Abstract

The pattern of secretion of plasma ACTH, hGH, TSH, LH, FSH and cortisol was studied in 12 menstrual cycles, representing 5 normal volunteers. Results were plotted by taking the LH-FSH midcycle peak as day 0. The typical menstrual cyclic LH and FSH pattern was observed in each case. ACTH, cortisol and hGH varied significantly throughout the menstrual cycle. ACTH was characterized by a decrease during the follicular phase, a nadir at day -2, followed by a significant increase to a peak at day 0, then a subsequent decrease and constant levels during the luteal phase until day +8. Cortisol was lowest in the follicular phase until day -4, and highest from day -2 to day 0. During the luteal phase, cortisol remained constant but was significantly higher than in the follicular phase (days -7 to -4). hGH showed a significant increase during the periovulatory period (days -3 to +3). No significant changes of plasma TSH were observed. These results suggest that pituitary hormones other than gonadotropins may be involved in the ovulatory mechanism, and reveal a degree of stimulation of the pituitary-adrenal axis without establishing whether the effect is direct or indirect.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 169283     DOI: 10.1210/jcem-41-3-431

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  19 in total

1.  No effect of menstrual cycle phase on glucose kinetics and fuel oxidation during moderate-intensity exercise.

Authors:  Tracy J Horton; Emily K Miller; Deborah Glueck; Kathleen Tench
Journal:  Am J Physiol Endocrinol Metab       Date:  2002-04       Impact factor: 4.310

2.  Differences between temporal patterns of plasma cortisol and corticosteroid-binding globulin binding capacity throughtout the twenty-four hour day and the menstrual cycle.

Authors:  A Angeli; R Frajria; L Dogliotti; C Crosazzo; F Rigoli; F Ceresa
Journal:  J Endocrinol Invest       Date:  1978-01       Impact factor: 4.256

Review 3.  The influence of gonadal hormones on neuronal excitability, seizures, and epilepsy in the female.

Authors:  Helen E Scharfman; Neil J MacLusky
Journal:  Epilepsia       Date:  2006-09       Impact factor: 5.864

Review 4.  Corticotropin-releasing factor (CRF) and stress-related reproductive failure: the brain as a state of the art or the ovary as a novel clue?

Authors:  R E Nappi; S Rivest
Journal:  J Endocrinol Invest       Date:  1995-12       Impact factor: 4.256

Review 5.  Influence of hormonal status on substrate utilization at rest and during exercise in the female population.

Authors:  Laurie Isacco; Pascale Duché; Nathalie Boisseau
Journal:  Sports Med       Date:  2012-04-01       Impact factor: 11.136

Review 6.  The relationship of the renin-angiotensin-aldosterone system to plasma gonadotropin, prolactin, and ovarian steroid patterns during the menstrual cycle.

Authors:  H Kaulhausen; G Leyendecker; G Benker; H Breuer
Journal:  Arch Gynakol       Date:  1978-07-19

7.  Hormonal influences on stress-induced neutrophil mobilization in health and chronic fatigue syndrome.

Authors:  J G Cannon; J B Angel; L W Abad; J O'Grady; N Lundgren; L Fagioli; A L Komaroff
Journal:  J Clin Immunol       Date:  1998-07       Impact factor: 8.317

8.  Dopamine receptor alteration in schizophrenia: neuroendocrine evidence.

Authors:  J Rotrosen; B M Angrist; S Gershon; E J Sachar; F S Halpern
Journal:  Psychopharmacology (Berl)       Date:  1976-12-21       Impact factor: 4.530

9.  Alteration of steroid hormone sensitivity during the cultivation of human mammary carcinoma cells.

Authors:  W E Simon; M Hänsel; M Dietel; L Matthiesen; M Albrecht; F Hölzel
Journal:  In Vitro       Date:  1984-03

Review 10.  Age-dependent and gender-dependent regulation of hypothalamic-adrenocorticotropic-adrenal axis.

Authors:  Johannes D Veldhuis; Animesh Sharma; Ferdinand Roelfsema
Journal:  Endocrinol Metab Clin North Am       Date:  2013-03-13       Impact factor: 4.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.